My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential.

    Shankar S, Chen Q, Siddiqui I, Sarva K, Srivastava RK.

    J Mol Signal. 2007 Aug 24;2:7.PMID: 17718901 [PubMed - in process]Related articlesFree article

    2.

    Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.

    Shankar S, Siddiqui I, Srivastava RK.

    Mol Cell Biochem. 2007 Oct;304(1-2):273-85. Epub 2007 Jul 17.PMID: 17636462 [PubMed - indexed for MEDLINE]Related articles

    4.

    Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis.

    Shankar S, Chen Q, Sarva K, Siddiqui I, Srivastava RK.

    J Mol Signal. 2007 Oct 4;2:10.PMID: 17916240 [PubMed - in process]Related articlesFree article

    5.

    Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.

    Hu H, Jiang C, Schuster T, Li GX, Daniel PT, Lü J.

    Mol Cancer Ther. 2006 Jul;5(7):1873-82.PMID: 16891474 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis.

    Shankar S, Ganapathy S, Chen Q, Srivastava RK.

    Mol Cancer. 2008 Jan 29;7:16.PMID: 18226269 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis.

    Shankar S, Ganapathy S, Srivastava RK.

    Clin Cancer Res. 2008 Nov 1;14(21):6855-66.PMID: 18980980 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms.

    Shankar S, Chen Q, Ganapathy S, Singh KP, Srivastava RK.

    Mol Cancer Ther. 2008 Aug;7(8):2328-38.PMID: 18723480 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria.

    Nagy K, Székely-Szüts K, Izeradjene K, Douglas L, Tillman M, Barti-Juhász H, Dominici M, Spano C, Luca Cervo G, Conte P, Houghton JA, Mihalik R, Kopper L, Peták I.

    Pathol Oncol Res. 2006;12(3):133-42. Epub 2006 Sep 23.PMID: 16998592 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression.

    Ivanov VN, Partridge MA, Johnson GE, Huang SX, Zhou H, Hei TK.

    Exp Cell Res. 2008 Mar 10;314(5):1163-76. Epub 2007 Dec 23.PMID: 18222423 [PubMed - indexed for MEDLINE]Related articles

    12.

    Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling.

    Fulda S, Debatin KM.

    Eur J Cancer. 2005 Mar;41(5):786-98. Epub 2005 Jan 21.PMID: 15763656 [PubMed - indexed for MEDLINE]Related articles

    14.

    Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the downregulation of cell survival proteins and upregulation of death receptors.

    Sung B, Park B, Yadav VR, Aggarwal BB.

    J Biol Chem. 2010 Feb 12. [Epub ahead of print]PMID: 20154087 [PubMed - as supplied by publisher]Related articlesFree article

    15.

    Mitochondrial transmembrane potential and reactive oxygen species generation regulate the enhanced effect of CCCP on TRAIL-induced SNU-638 cell apoptosis.

    Chaudhari AA, Seol JW, Kang SJ, Park SY.

    J Vet Med Sci. 2008 Jun;70(6):537-42.PMID: 18628592 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.

    Rosato RR, Almenara JA, Coe S, Grant S.

    Cancer Res. 2007 Oct 1;67(19):9490-500.PMID: 17909059 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.

    Gill C, Walsh SE, Morrissey C, Fitzpatrick JM, Watson RW.

    Prostate. 2007 Nov 1;67(15):1641-53.PMID: 17823925 [PubMed - indexed for MEDLINE]Related articles

    18.

    BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells.

    Huang S, Okumura K, Sinicrope FA.

    Clin Cancer Res. 2009 Jan 1;15(1):150-9.PMID: 19118042 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro.

    Mao HL, Liu PS, Zheng JF, Zhang PH, Zhou LG, Xin G, Liu C.

    Pharmacol Res. 2007 Dec;56(6):483-92. Epub 2007 Sep 15.PMID: 18029193 [PubMed - indexed for MEDLINE]Related articles

    20.

    Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.

    Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.

    Mol Cancer Ther. 2009 Jun;8(6):1596-605. Epub 2009 Jun 9.PMID: 19509267 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk